← FDA DRUG APPROVALS

FDA ANDA · ANDA202644

NIFEDIPINE

Sponsor: HERITAGE PHARMA

APPLICATION
ANDA202644
TYPE
ANDA
ORIGINAL APPROVAL
2013-04-25
LATEST ACTION
2016-01-26
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

NIFEDIPINEPrescription
NIFEDIPINE 20MG · CAPSULE · ORAL
NIFEDIPINEPrescription
NIFEDIPINE 10MG · CAPSULE · ORAL

Approval history

2016-01-26Labeling · Supplement 4 · standardAP
2014-12-11Labeling · Supplement 1 · standardAP
2014-12-11Labeling · Supplement 2 · standardAP
2013-04-25UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →